Loading...
Griseofulvin — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Griseofulvin
2025-Q4
Comprehensive analysis of India’s griseofulvin export trade — suppliers, buyers, prices, routes, and every shipment record.
125
Shipments
$1.57M
Trade Value
55
Suppliers
56
Buyers
45
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/griseofulvin
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s griseofulvin trade — 2025-Q4
KEY TAKEAWAY
Griseofulvin 2025-Q4 exports total $1.6M across 45 countries, with CIPLA LTD commanding 17.4% market share.
TOTAL SHIPMENTS
125
2025-Q4
EXPORT VALUE
$1.6M
FOB USD
TOTAL QUANTITY
9.0M
units shipped
INDIAN SUPPLIERS
55
unique exporters
GLOBAL BUYERS
56
unique importers
DESTINATIONS
45
countries
MEDIAN UNIT PRICE
$0.552
per unit
TOP-5 SHARE
58.2%
of total USD
BRANDED SHARE
64.8%
81 shipments
DOSAGE FORMS
3
product types
6 KEY FINDINGS
1
CIPLA LTD is India's #1 Griseofulvin exporter with $273.1K (17.4% market share).→ §5, Indian Supplier Rankings
2
Griseofulvin reached 45 countries, with United States as the top destination ($345.4K).→ §4, Global Destination Map
3
Market concentration is low (HHI: 886) — top 10 suppliers control 80.6% of exports.→ §5, Indian Supplier Rankings
4
92.9% of buyers (52 of 56) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (71.5%) across 3 dosage forms.→ §7, Price Benchmarks
6
44 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 CIPLA LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian griseofulvin exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Griseofulvin report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial griseofulvin trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian griseofulvin suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Griseofulvin India trade report
Product scope
Griseofulvin
All variants merged — branded and generic formulations of griseofulvin
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
125
Every commercial griseofulvin trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $404.1K, Nov $892.0K, Dec $273.8K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$404.1K
Oct USD
23 shipments
2
$892.0K
Nov USD
+120.7% MoM
3
$273.8K
Dec USD
-69.3% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 120.7% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $404K, making it the middle month by value.
Fig 3.2 Q4 cumulative USD reached $1.6M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $488K rise in Nov, $618K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $404K | 23 shipments |
| Nov | $892K | 48 shipments |
| Dec | $274K | 54 shipments |
| Q4 Total | $1.6M | 125 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Uganda held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: LEBEN LABORATORIES PVT LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import griseofulvin from India, how much they buy, and who supplies each market
KEY TAKEAWAY
United States absorbs 22.0% of India’s 2025-Q4 griseofulvin trade ($345.4K). Beyond the top 10 destinations, 44 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 23 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 44 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much griseofulvin India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$130K
8.3% of trade
9 countries · 24 shipments
Europe
$124K
7.9% of trade
3 countries · 5 shipments
Americas
$365K
23.2% of trade
9 countries · 21 shipments
Africa
$940K
59.9% of trade
23 countries · 72 shipments
Oceania
$11K
0.7% of trade
1 countries · 3 shipments
Fig 4.1 United States is the #1 corridor ($345K) — 30 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian griseofulvin it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | United States | $345K | 4 | CIPLA LTD | $273K | AMNEAL PHARMACEUTICALS PVT LTD | $72K | — | — |
| 2 | Senegal | $221K | 3 | SIDHAANT LIFE SCIENCES PVT LTD | $221K | — | — | — | — |
| 3 | DR Congo | $122K | 8 | VIDACARE MEDICA PVT LTD | $113K | LEBEN LABORATORIES PVT LTD | $9K | FLOURISH PHARMA | $621 |
| 4 | South Africa | $111K | 11 | AGOG PHARMA LTD | $108K | HANSI TRADERS | $3K | — | — |
| 5 | Netherlands | $99K | 3 | MICRO LABS LTD | $84K | MEDOPHARM | $15K | — | — |
| 6 | Uganda | $96K | 3 | LEBEN LABORATORIES PVT LTD | $74K | AFRICURE PHARMACEUTICALS (INDIA) PVT LTD | $22K | — | — |
| 7 | United Arab Emirates | $71K | 11 | INNOVA CAPTAB LTD | $31K | MICRO LABS LTD | $22K | SMP LIFECARE | $11K |
| 8 | Nigeria | $54K | 1 | LABORATE PHARMACEUTICALS INDIA LTD | $54K | — | — | — | — |
| 9 | Tanzania | $50K | 3 | AGOG PHARMA LTD | $50K | — | — | — | — |
| 10 | Zambia | $46K | 3 | LEBEN LABORATORIES PVT LTD | $34K | AFRICURE PHARMACEUTICALS (INDIA) PVT LTD | $11K | PATSONS INTERNATIONAL | $1K |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 8.3% of USD — but United States is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
22.0%
#1 country share
United States alone
57.2%
Top 5 share
5 of 45 countries
89.3%
Top 15 share
Long tail of 30 countries = 10.7%
HHI 960
Destination HHI
Competitive spread
45
Countries served
Global pharma reach from India
23
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
55 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
CIPLA LTD ($273.1K, 17.4% share) and SIDHAANT LIFE SCIENCES PVT LTD ($220.8K) together control 31.5% of India’s 2025-Q4 griseofulvin trade. The top 5 suppliers hold 58.2%. 55 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian griseofulvin suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 CIPLA LTD leads by $52K over SIDHAANT LIFE SCIENCES PVT LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: AURA LIFECARE PVT is #18 by value but #10 by volume.
Fig 5.2 LEBEN LABORATORIES PVT LTD also leads by shipment count (7) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: AURA LIFECARE PVT moves from #10 by volume to #18 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 55 griseofulvin suppliers split into strategic segments
KEY TAKEAWAY
14 suppliers (25%) generate 87.6% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 CIPLA LTD and SIDHAANT LIFE SCIENCES PVT LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 87.6% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | CIPLA LTD | 2 | 2 | $273K |
| 2 | SIDHAANT LIFE SCIENCES PVT LTD | 1 | 1 | $221K |
| 3 | AGOG PHARMA LTD | 1 | 3 | $190K |
| 4 | LEBEN LABORATORIES PVT LTD | 1 | 5 | $117K |
| 5 | VIDACARE MEDICA PVT LTD | 1 | 1 | $113K |
| 6 | MICRO LABS LTD | 1 | 2 | $106K |
| 7 | AFRICURE PHARMACEUTICALS (INDIA) PVT LTD | 1 | 3 | $78K |
| 8 | AMNEAL PHARMACEUTICALS PVT LTD | 1 | 1 | $72K |
| 9 | LABORATE PHARMACEUTICALS INDIA LTD | 1 | 1 | $54K |
| 10 | CIRON DRUGS AND PHARMACEUTICALS PVT LTD | 1 | 2 | $42K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the griseofulvin manufacturing hubs
KEY TAKEAWAY
Parel Mumbai Maharashtra and Gurugram together account for $453K of India’s 2025-Q4 griseofulvin trade.
Fig 5.5 Parel Mumbai Maharashtra (1 exporters, $273K) and Gurugram (1 exporters, $180K) are India’s griseofulvin capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
58.2%
Top 5 share
5 of 55 suppliers
80.6%
Top 10 share
10 of 55 suppliers
87.6%
Top 25% share
14 suppliers = 88% USD
HHI 886
Supplier HHI
Competitive
55
Total suppliers
shipped Griseofulvin in 2025-Q4
20+ cities
Indian hubs
Parel Mumbai Maharashtra and Gurugram lead
§5.2 Coming next: 2 exporter deep-dive profiles
Each of the top 2 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | AGOG PHARMA LTD | $190K |
| #2 | LEBEN LABORATORIES PVT LTD | $117K |
#3
EXPORTER PROFILE #1 OF 2
AGOG PHARMA LTD
Vasai East · India’s #3 griseofulvin supplier by USD · 2025-Q4
2025-Q4 USD
$190K
12.1% market share
SHIPMENTS
6
avg $32K/ship
COUNTRIES
3
destination markets
BUYERS
4
3 single-sourced
BRANDED
33%
of shipments
DOSAGE FORMS
1
product types
TOP 3 DESTINATIONS
South Africa is the #1 market at $108K (57% of trade), followed by Tanzania at $50K. 3 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | South Africa | $108K | 2 | 56.6% |
| 2 | Tanzania | $50K | 3 | 26.3% |
| 3 | Kenya | $33K | 1 | 17.1% |
MONTHLY TREND
Nov peaked at $157K. Oct was the weakest at $0.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 3/3 LOCKED IN
3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| RGCO (PTY) LTD | South Africa | $54K | ⚠ Locked |
| Undisclosed buyer | South Africa | $54K | N/A |
| PLANET PHARMACEUTICALS… | Tanzania | $50K | ⚠ Locked |
| GITTOES PHARMACEUTICAL… | Kenya | $33K | ⚠ Locked |
#3
EXPORTER PROFILE #1 OF 2 — TRADE FLOW MAP
AGOG PHARMA LTD — Supplier → Country → Importer
3 destination countries, top 5 importers per country
Fig 5.P1.3 South Africa absorbs $108K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 2 importers per destination.
#4
EXPORTER PROFILE #2 OF 2
LEBEN LABORATORIES PVT LTD
Akola. Maharashtra · India’s #4 griseofulvin supplier by USD · 2025-Q4
2025-Q4 USD
$117K
7.4% market share
SHIPMENTS
7
avg $17K/ship
COUNTRIES
5
destination markets
BUYERS
5
5 single-sourced
BRANDED
86%
of shipments
DOSAGE FORMS
1
product types
TOP 5 DESTINATIONS
Uganda is the #1 market at $74K (63% of trade), followed by Zambia at $34K. 5 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Uganda | $74K | 2 | 62.9% |
| 2 | Zambia | $34K | 1 | 29.0% |
| 3 | DR Congo | $9K | 1 | 7.9% |
| 4 | Malawi | $173 | 2 | 0.1% |
| 5 | Ethiopia | $122 | 1 | 0.1% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $74K.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 5/5 LOCKED IN
5 of 5 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| ZEE PHARMACEUTICALS LTD | Uganda | $74K | ⚠ Locked |
| LUSAKA MEDI CAMP LTD | Zambia | $34K | ⚠ Locked |
| MEDLINK PHARMACEUTICAL… | DR Congo | $9K | ⚠ Locked |
| PHARMAVET LTD | Malawi | $173 | ⚠ Locked |
| KARE PHARMACEUTICALS PLC | Ethiopia | $122 | ⚠ Locked |
#4
EXPORTER PROFILE #2 OF 2 — TRADE FLOW MAP
LEBEN LABORATORIES PVT LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P2.3 Uganda absorbs $74K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
56 importers across 45 countries — who is buying Indian griseofulvin and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 78.1% of total USD. 93% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian griseofulvin. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 CIPLA USA INC is the #1 importer at $273K (17.4%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
93%
Single-source
52 buyers rely on exactly 1 Indian supplier
4%
Dual-source
2 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
4%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source griseofulvin from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
United Arab Emirates 4 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| NOOR AL DAR GENERAL TR… | INNOVA CAPTAB LTD | $31K | $0.539 | Tablet |
| IMPERIAL MEDICAL SOLUT… | MICRO LABS LTD | $22K | $72.751 | Tablet |
| EPHESUS GENERAL TRADIN… | SMP LIFECARE | $11K | $0.461 | Suspension |
| GUMAR INTERNATIONAL (F… | AURA LIFECARE PVT LTD | $10K | $0.532 | — |
DR Congo 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| STE PRINCE PHARMA SARL | VIDACARE MEDICA PVT … | $113K | $0.039 | Tablet |
| MEDLINK PHARMACEUTICAL… | LEBEN LABORATORIES P… | $9K | $0.048 | Tablet |
| PRINCE PHARMA | FLOURISH PHARMA | $621.441 | $0.0004 | Tablet |
Zambia 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| LUSAKA MEDI CAMP LTD | LEBEN LABORATORIES P… | $34K | $0.059 | Tablet |
| AUGUSTA LTD | AFRICURE PHARMACEUTI… | $11K | $54.994 | Tablet |
| LUSAKA PHARMACEUTICALS… | PATSONS INTERNATIONAL | $1K | $0.278 | Tablet |
Mozambique 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ACE HEALTH CARE LDA | BIOMATRIX HEALTHCARE… | $22K | $5.964 | Tablet |
| MAPUTO HEALTH CARE LDA | KAUSIKH THERAPEUTICS… | $13K | $6.682 | Tablet |
| SHANI LDA | INTERMED LABORATORIE… | $345.813 | $0.036 | Tablet |
Angola 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PRINCE FARMA SA | V 2 IMPEX | $13K | $0.190 | — |
| LUA COMERCIO GERAL LIM… | AURA LIFECARE PVT LTD | $3K | $1.640 | Cream |
| BALAXI HEALTHCARE ANGO… | BALAXI PHARMACEUTICA… | $36.219 | $0.0018 | Cream |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | CIPLA USA INC | United States | $273K | $137K | Premium |
| 2 | P.N.A | Senegal | $180K | $90K | Premium |
| 3 | STE PRINCE PHARMA SARL | DR Congo | $113K | $19K | Mid |
| 4 | ZEE PHARMACEUTICALS … | Uganda | $74K | $37K | Premium |
| 5 | AMNEAL PHARMACEUTICA… | United States | $72K | $36K | Premium |
| 6 | IMRES B.V | Netherlands | $57K | $29K | Mid |
| 7 | RGCO (PTY) LTD | South Africa | $54K | $54K | Premium |
| 8 | PLANET PHARMACEUTICA… | Tanzania | $50K | $17K | Mid |
| 9 | AFRICURE PHARMACEUTI… | Burkina Faso | $45K | $45K | Premium |
| 10 | LUSAKA MEDI CAMP LTD | Zambia | $34K | $34K | Mid |
| 11 | GITTOES PHARMACEUTIC… | Kenya | $33K | $33K | Mid |
| 12 | GEORGE STEUART HEALT… | Sri Lanka | $32K | $16K | Mid |
| 13 | NOOR AL DAR GENERAL … | United Arab Emirates | $31K | $8K | Budget |
| 14 | ROYAL PHARMA 2011 UG… | Uganda | $22K | $22K | Mid |
| 15 | IMPERIAL MEDICAL SOL… | United Arab Emirates | $22K | $11K | Budget |
| 16 | ACE HEALTH CARE LDA | Mozambique | $22K | $22K | Mid |
| 17 | ROXIN GHANA LTD | Ghana | $19K | $10K | Budget |
| 18 | PLANET PHARMACEUTICA… | Zimbabwe | $14K | $7K | Budget |
| 19 | MAPUTO HEALTH CARE LDA | Mozambique | $13K | $7K | Budget |
| 20 | PRINCE FARMA SA | Angola | $13K | $13K | Budget |
| 21 | BIOGLASS PHARMACEUTI… | Venezuela | $12K | $12K | Budget |
| 22 | EPHESUS GENERAL TRAD… | United Arab Emirates | $11K | $11K | Budget |
| 23 | AUGUSTA LTD | Zambia | $11K | $11K | Budget |
| 24 | GUMAR INTERNATIONAL … | United Arab Emirates | $10K | $5K | Budget |
| 25 | MEDLINK PHARMACEUTIC… | DR Congo | $9K | $9K | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 CIPLA LTD → CIPLA USA INC is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian griseofulvin prices vary by supplier, country and dosage form
KEY TAKEAWAY
Griseofulvin prices span 1533060× ($0.0002 → $279.83). The coefficient of variation is 2.62. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0002 | Lowest observed unit price |
| P5 | $0.022 | 5th percentile |
| P25 | $0.154 | 25th percentile (Q1) |
| Median | $0.552 | 50th percentile (Q2) |
| P75 | $6.68 | 75th percentile (Q3) |
| P95 | $108.70 | 95th percentile |
| Max | $279.83 | Highest observed unit price |
| Mean | $18.79 | Arithmetic average |
| CV | 262% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 SIDHAANT LIFE SCIENCES PVT LTD prices at $279.83/unit vs market median $0.552.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. LEBEN LABORATORIES PVT Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. CIPLA LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. V 2 IMPEX Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. LABORATE PHARMACEUTICALS INDIA Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Oct 2025 | SIDHAANT LIFE SC… | Senegal | Tablet | 444 | $139K | $312.96 | Specialty / small-batch |
| Nov 2025 | SIDHAANT LIFE SC… | Senegal | Tablet | 147 | $41K | $279.83 | Specialty / small-batch |
| Nov 2025 | SIDHAANT LIFE SC… | Senegal | Tablet | 147 | $41K | $279.83 | Specialty / small-batch |
| Dec 2025 | BAL PHARMA LTD | Zimbabwe | Tablet | 14 | $3K | $193.07 | Specialty / small-batch |
| Dec 2025 | BAL PHARMA LTD | Zimbabwe | Tablet | 58 | $11K | $193.07 | Specialty / small-batch |
| Dec 2025 | MICRO LABS LTD | United Arab Emirates | Tablet | 100 | $11K | $110.70 | Specialty / small-batch |
| Nov 2025 | MICRO LABS LTD | Netherlands | Tablet | 385 | $42K | $108.70 | Specialty / small-batch |
| Nov 2025 | MICRO LABS LTD | Netherlands | Tablet | 385 | $42K | $108.70 | Specialty / small-batch |
| Nov 2025 | AGOG PHARMA LTD | Tanzania | Tablet | 495 | $49K | $99.64 | Specialty / small-batch |
| Oct 2025 | BAL PHARMA LTD | Mozambique | Tablet | 42 | $4K | $94.15 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | BALAXI PHARMACEU… | Angola | Cream | 20K | $36.22 | $0.0018 | |
| Dec 2025 | RYVIS PHARMA PVT… | Jamaica | Tablet | 1K | $6.72 | $0.0047 | Bulk generic tablet |
| Dec 2025 | ARIHANT EXPORTERS | Papua New Guinea | Tablet | 3K | $28.70 | $0.011 | |
| Dec 2025 | SARA TRADING CORP | Saint Lucia | Tablet | 10 | $0.259 | $0.026 | Small sample / trial shipment |
| Dec 2025 | DISTINCT IMPEX P… | Iraq | Suspension | 50 | $1.31 | $0.026 | Small sample / trial shipment |
| Dec 2025 | DISTINCT IMPEX P… | Iraq | Suspension | 50 | $1.31 | $0.026 | Small sample / trial shipment |
| Dec 2025 | RYVIS PHARMA PVT… | Jamaica | Tablet | 110 | $3.31 | $0.030 | Small sample / trial shipment |
| Dec 2025 | VEA IMPEX (I) PV… | Saint Kitts and Nevis | Suspension | 50 | $1.53 | $0.031 | Small sample / trial shipment |
| Dec 2025 | SANAR HEALTHCARE… | Haiti | Tablet | 67K | $2K | $0.031 | |
| Dec 2025 | SARA TRADING CORP | Saint Lucia | Suspension | 13 | $0.496 | $0.038 | Small sample / trial shipment |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship griseofulvin, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Griseofulvin leaves India through 16+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), MUMBAI AIR (SAHAR), PATLI ICD) handle 87.8% of total USD. SEA moves 57% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $604K — top 16 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 NEWARK, NJ is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 57% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$712K
45.4% of USD · 56.8% of ships
AIR
$458K
29.2% of USD · 28.8% of ships
ICD
$391K
24.9% of USD · 13.6% of ships
ROAD
$9K
0.6% of USD · 0.8% of ships
Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → Africa ($528K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Jamaica is the most concentrated destination (HHI 10000, 1 suppliers). United Arab Emirates is the most competitive (HHI 3218).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Jamaica (HHI 10,000) is the most concentrated — United Arab Emirates (HHI 3,218) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| CIPLA USA INC | United States | CIPLA LTD | $273K | 2 | HIGH |
| P.N.A | Senegal | SIDHAANT LIFE SC… | $180K | 2 | HIGH |
| STE PRINCE PHARMA SARL | DR Congo | VIDACARE MEDICA … | $113K | 6 | HIGH |
| ZEE PHARMACEUTICALS … | Uganda | LEBEN LABORATORI… | $74K | 2 | MEDIUM |
| AMNEAL PHARMACEUTICA… | United States | AMNEAL PHARMACEU… | $72K | 2 | MEDIUM |
| RGCO (PTY) LTD | South Africa | AGOG PHARMA LTD | $54K | 1 | MEDIUM |
| PLANET PHARMACEUTICA… | Tanzania | AGOG PHARMA LTD | $50K | 3 | MEDIUM |
| AFRICURE PHARMACEUTI… | Burkina Faso | AFRICURE PHARMAC… | $45K | 1 | MEDIUM |
Conclusion: 52 buyers depend on exactly one Indian supplier, representing $1.2M in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| United States | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Senegal | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| DR Congo | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| South Africa | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Netherlands | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Uganda | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nigeria | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Tanzania | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Zambia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Burkina Faso | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Mozambique | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Ghana | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Sri Lanka | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 12 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in United States | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Jamaica lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Somalia (2 suppliers) | This Q | HIGH |
| A6 | Enter DR Congo (3 suppliers) | This Q | MED |
| A8 | Build Senegal distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (BAL PHARMA) | This Q | MED |
| A7 | Register for United States tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Somalia | Africa | 2 | $12K | +6207.7% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | DR Congo | Africa | 3 | $122K | +492.7% | LOW | Growing 493% with only 3 competitors |
| 3 | United States | Other | 2 | $345K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Uganda | Africa | 2 | $96K | +229.4% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Senegal | Africa | 1 | $221K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | South Africa | Africa | 2 | $111K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Netherlands | Other | 2 | $99K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Nigeria | Africa | 1 | $54K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Tanzania | Africa | 1 | $50K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Zambia | Africa | 3 | $46K | -100% | LOW | Low competition (3 suppliers), accessible market |
| 11 | Burkina Faso | Africa | 1 | $45K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Mozambique | Africa | 4 | $39K | -98.7% | LOW | Low competition (4 suppliers), accessible market |
| 13 | Ghana | Africa | 2 | $37K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Kenya | Africa | 1 | $33K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Sri Lanka | Asia | 1 | $32K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 125 2025-Q4 Griseofulvin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/griseofulvin
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 125 2025-Q4 griseofulvin shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian griseofulvin shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
125
across all regions
TOTAL USD
$1.57M
2025-Q4 FOB value
UNITS
9.0M
tablets, capsules, etc.
SUPPLIERS
55
Indian exporters
BUYERS
56
global importers
COUNTRIES
45
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $940K (59.9%), spanning 23 countries.
55 Indian suppliers shipped to 56 buyers across 45 countries — average shipment value $13K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
23 countries · 72 shipments · $940K · 28 Indian suppliers · 35 buyers
SHIPMENTS
72
USD
$940K
COUNTRIES
23
SUPPLIERS
28
BUYERS
35
HHI
1,403
competitive
Top 23 destination countries in Africa
1
Senegal (23.5%)
$221K
2
DR Congo (13.0%)
$122K
3
South Africa (11.8%)
$111K
4
Uganda (10.2%)
$96K
5
Nigeria (5.7%)
$54K
6
Tanzania (5.3%)
$50K
7
Zambia (4.9%)
$46K
8
Burkina Faso (4.8%)
$45K
9
Mozambique (4.2%)
$39K
10
Ghana (4.0%)
$37K
11
Kenya (3.5%)
$33K
12
Ethiopia (2.6%)
$24K
13
Angola (2.2%)
$21K
14
Zimbabwe (1.5%)
$14K
15
Somalia (1.3%)
$12K
16
Cameroon (0.8%)
$7K
17
Guinea-Bissau (0.3%)
$3K
18
Liberia (0.2%)
$2K
19
Gabon (0.1%)
$1K
20
Equatorial Guinea (0.1%)
$846.80
21
Lesotho (0.1%)
$509.28
22
Mauritius (0.0%)
$245.66
23
Malawi (0.0%)
$172.92
Top 28 Indian suppliers into Africa
1
SIDHAANT LIFE SCIENCES PVT LTD
$221K
2
AGOG PHARMA LTD
$190K
3
LEBEN LABORATORIES PVT LTD
$117K
4
VIDACARE MEDICA PVT LTD
$113K
5
AFRICURE PHARMACEUTICALS (INDIA) PVT LTD
$78K
6
LABORATE PHARMACEUTICALS INDIA LTD
$54K
7
CIRON DRUGS AND PHARMACEUTICALS PVT LTD
$42K
8
BIOMATRIX HEALTHCARE PVT LTD
$22K
9
RONAK EXIM PVT LTD
$19K
10
BAL PHARMA LTD
$18K
11
KAUSIKH THERAPEUTICS PVT LTD
$13K
12
V 2 IMPEX
$13K
13
SANJEEVANI BIO-TECH EXIM PVT LTD
$12K
14
SAVORITE PHARMACEUTICALS PVT LTD
$7K
15
AURA LIFECARE PVT LTD
$6K
16
HANSI TRADERS
$3K
17
BEYOND LIFE LINE
$3K
18
BIO PHARMA PRIMO IMPEX
$2K
19
PATSONS INTERNATIONAL
$1K
20
MEDNEXT BIOTECH LTD
$1K
21
SONIA LABORATORY PVT LTD
$1K
22
EXGEN CARE PVT LTD
$887.58
23
FLOURISH PHARMA
$621.44
24
NUMED PHARMA DISTRIBUTOR
$509.28
25
INTERMED LABORATORIES PVT LTD
$345.81
26
SAVA HEALTHCARE LTD
$245.66
27
MEDISKY HEALTHCARE
$194.44
28
BALAXI PHARMACEUTICALS LTD
$36.22
Top 30 Africa importers
1
P.N.A · Senegal
$180K
2
STE PRINCE PHARMA SARL · DR Congo
$113K
3
ZEE PHARMACEUTICALS LTD · Uganda
$74K
4
RGCO (PTY) LTD · South Africa
$54K
5
PLANET PHARMACEUTICALS LTD · Tanzania
$50K
6
AFRICURE PHARMACEUTICALS BURKINA S · Burkina Faso
$45K
7
LUSAKA MEDI CAMP LTD · Zambia
$34K
8
GITTOES PHARMACEUTICALS LTD · Kenya
$33K
9
ROYAL PHARMA 2011 UGANDA LTD · Uganda
$22K
10
ACE HEALTH CARE LDA · Mozambique
$22K
11
ROXIN GHANA LTD · Ghana
$19K
12
PLANET PHARMACEUTICALS & CHEMICALS · Zimbabwe
$14K
13
MAPUTO HEALTH CARE LDA · Mozambique
$13K
14
PRINCE FARMA SA · Angola
$13K
15
AUGUSTA LTD · Zambia
$11K
16
MEDLINK PHARMACEUTICALS LTD · DR Congo
$9K
17
GUMAR INTERNATIONAL (FZC) · Angola
$3K
18
LUA COMERCIO GERAL LIMITADA · Angola
$3K
19
GROUPE SIMA-AICHA COMMERCIAL SARL · Guinea-Bissau
$3K
20
ELTON TATENDA GUWU · South Africa
$2K
21
MINISTRY OF HEALTH & SOCIAL WELFARE · Liberia
$2K
22
LUSAKA PHARMACEUTICALS LTD · Zambia
$1K
23
OFFICE PHARMACEUTIQUE NATIONALE · Gabon
$1K
24
SONIA PHARMACY · Equatorial Guinea
$846.80
25
PRINCE PHARMA · DR Congo
$621.44
26
LIFELINE PHARMACEUTICALS OF · Lesotho
$509.28
27
SHANI LDA · Mozambique
$345.81
28
REGENCY EXIM TRADE LTD · Mauritius
$245.66
29
OCEAN HEALTHCARE · Somalia
$194.44
30
SONIA FARMACIA SARL · Guinea-Bissau
$176.94
Top 4 dosage forms
1
Tablet
$802K
2
Suspension
$64K
3
Unknown
$58K
4
Cream
$15K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 11 | $258K | $23K |
| Nov | 32 | $459K | $14K |
| Dec | 29 | $223K | $8K |
Shipment register · 72 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — SIDHAANT LIFE SCIENCES PVT LTD · 3 shipments · $221K | |||||||||||
| 1 | Oct 2025 | P.N.A | Senegal | Tablet | 444 | KGS | $312.96 | $139K | PATLI ICD | DAKAR | ICD |
| 2 | Nov 2025 | P.N.A | Senegal | Tablet | 147 | KGS | $279.83 | $41K | PATLI ICD | Dakar | ICD |
| 3 | Nov 2025 | UNKNOWN BUYER | Senegal | Tablet | 147 | KGS | $279.83 | $41K | PATLI ICD | Dakar | ICD |
| SUPPLIER #2 — AGOG PHARMA LTD · 6 shipments · $190K | |||||||||||
| 4 | Nov 2025 | RGCO (PTY) LTD | South Africa | Tablet | 600 | KGS | $89.85 | $54K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 5 | Nov 2025 | UNKNOWN BUYER | South Africa | Tablet | 600 | KGS | $89.85 | $54K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 6 | Nov 2025 | PLANET PHARMACEUTICALS LTD | Tanzania | Tablet | 495 | KGS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | DAR ES SALAM (DARESS | AIR |
| 7 | Nov 2025 | PLANET PHARMACEUTICALS LTD | Tanzania | Tablet | 495 | KGS | $99.64 | $49K | MUMBAI AIR (SAHAR) | DAR ES SALAM (DARESS | AIR |
| 8 | Dec 2025 | PLANET PHARMACEUTICALS LTD | Tanzania | Tablet | 740 | KGS | $1.06 | $783.83 | NHAVA SHEVA SEA (JNPT) | Dar Es Salaam | SEA |
| 9 | Dec 2025 | GITTOES PHARMACEUTICALS LTD | Kenya | Tablet | 389 | KGS | $83.63 | $33K | NHAVA SHEVA SEA (JNPT) | Mombasa | SEA |
| SUPPLIER #3 — LEBEN LABORATORIES PVT LTD · 7 shipments · $117K | |||||||||||
| 10 | Oct 2025 | MEDLINK PHARMACEUTICALS LTD | DR Congo | Tablet | 192.0K | TBS | $0.048 | $9K | NHAVA SHEVA SEA (JNPT) | Dar Es Salaam | SEA |
| 11 | Oct 2025 | LUSAKA MEDI CAMP LTD | Zambia | Tablet | 576.0K | TBS | $0.059 | $34K | NHAVA SHEVA SEA (JNPT) | Dar Es Salaam | SEA |
| 12 | Dec 2025 | PHARMAVET LTD | Malawi | Tablet | 422.4K | TBS | $0.0002 | $77.10 | MUMBAI AIR (SAHAR) | LILONGWE | AIR |
| 13 | Dec 2025 | PHARMAVET LTD | Malawi | Tablet | 540.0K | TBS | $0.0002 | $95.82 | MUMBAI AIR (SAHAR) | LILONGWE | AIR |
| 14 | Dec 2025 | KARE PHARMACEUTICALS PLC | Ethiopia | Tablet | 230.4K | TBS | $0.0005 | $121.76 | NHAVA SHEVA SEA (JNPT) | Djibouti | SEA |
| 15 | Dec 2025 | ZEE PHARMACEUTICALS LTD | Uganda | Tablet | 216.5K | TBS | $0.046 | $10K | NHAVA SHEVA SEA (JNPT) | Kampala | SEA |
| 16 | Dec 2025 | ZEE PHARMACEUTICALS LTD | Uganda | Tablet | 1.4M | TBS | $0.046 | $64K | NHAVA SHEVA SEA (JNPT) | Kampala | SEA |
| SUPPLIER #4 — VIDACARE MEDICA PVT LTD · 6 shipments · $113K | |||||||||||
| 17 | Nov 2025 | STE PRINCE PHARMA SARL | DR Congo | Tablet | 500.0K | NOS | $0.039 | $19K | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| 18 | Nov 2025 | STE PRINCE PHARMA SARL | DR Congo | Tablet | 500.0K | NOS | $0.039 | $19K | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| 19 | Nov 2025 | STE PRINCE PHARMA SARL | DR Congo | Tablet | 500.0K | NOS | $0.039 | $19K | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| 20 | Dec 2025 | STE PRINCE PHARMA SARL | DR Congo | Tablet | 500.0K | NOS | $0.039 | $20K | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| 21 | Dec 2025 | STE PRINCE PHARMA SARL | DR Congo | Tablet | 500.0K | NOS | $0.039 | $19K | NHAVA SHEVA SEA (JNPT) | Dar Es Salaam | SEA |
| 22 | Dec 2025 | STE PRINCE PHARMA SARL | DR Congo | Tablet | 380.0K | NOS | $0.040 | $15K | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| SUPPLIER #5 — AFRICURE PHARMACEUTICALS (INDIA) PVT LTD · 3 shipments · $78K | |||||||||||
| 23 | Oct 2025 | ROYAL PHARMA 2011 UGANDA LTD | Uganda | Tablet | 500 | NOS | $44.66 | $22K | NHAVA SHEVA SEA (JNPT) | Kampala | SEA |
| 24 | Oct 2025 | AUGUSTA LTD | Zambia | Tablet | 196 | NOS | $54.99 | $11K | NHAVA SHEVA SEA (JNPT) | Lusaka | SEA |
| 25 | Nov 2025 | AFRICURE PHARMACEUTICALS BURKINA S | Burkina Faso | 1.1K | NOS | $40.93 | $45K | NHAVA SHEVA SEA (JNPT) | Ouagadougou | SEA | |
| SUPPLIER #6 — LABORATE PHARMACEUTICALS INDIA LTD · 1 shipments · $54K | |||||||||||
| 26 | Nov 2025 | UNLISTED BUYER | Nigeria | Tablet | 7.0K | NOS | $7.70 | $54K | PATLI ICD | Apapa | ICD |
| SUPPLIER #7 — CIRON DRUGS AND PHARMACEUTICALS PVT LTD · 2 shipments · $42K | |||||||||||
| 27 | Nov 2025 | UNLISTED BUYER | Ethiopia | Suspension | 20.0K | NOS | $1.20 | $24K | NHAVA SHEVA SEA (JNPT) | Djibouti | SEA |
| 28 | Dec 2025 | UNLISTED BUYER | Ghana | Suspension | 19.4K | NOS | $0.918 | $18K | NHAVA SHEVA SEA (JNPT) | Tema | SEA |
| SUPPLIER #8 — BIOMATRIX HEALTHCARE PVT LTD · 1 shipments · $22K | |||||||||||
| 29 | Oct 2025 | ACE HEALTH CARE LDA | Mozambique | Tablet | 3.6K | NOS | $5.96 | $22K | AHMEDABAD ICD | MAPUTO | ICD |
| SUPPLIER #9 — RONAK EXIM PVT LTD · 2 shipments · $19K | |||||||||||
| 30 | Nov 2025 | ROXIN GHANA LTD | Ghana | Suspension | 40.0K | NOS | $0.387 | $15K | NHAVA SHEVA SEA (JNPT) | Tema | SEA |
| 31 | Dec 2025 | ROXIN GHANA LTD | Ghana | Suspension | 10.2K | NOS | $0.387 | $4K | NHAVA SHEVA SEA (JNPT) | Tema | SEA |
| SUPPLIER #10 — BAL PHARMA LTD · 3 shipments · $18K | |||||||||||
| 32 | Oct 2025 | UNLISTED BUYER | Mozambique | Tablet | 42 | KGS | $94.15 | $4K | NHAVA SHEVA SEA (JNPT) | Lusaka | SEA |
| 33 | Dec 2025 | PLANET PHARMACEUTICALS & CHEMICALS | Zimbabwe | Tablet | 14 | KGS | $193.07 | $3K | DELHI AIR | HARARE | AIR |
| 34 | Dec 2025 | PLANET PHARMACEUTICALS & CHEMICALS | Zimbabwe | Tablet | 58 | KGS | $193.07 | $11K | DELHI AIR | HARARE | AIR |
| SUPPLIER #11 — KAUSIKH THERAPEUTICS PVT LTD · 2 shipments · $13K | |||||||||||
| 35 | Nov 2025 | MAPUTO HEALTH CARE LDA | Mozambique | Tablet | 1.0K | NOS | $6.68 | $7K | CHENNAI SEA | Maputo | SEA |
| 36 | Nov 2025 | MAPUTO HEALTH CARE LDA | Mozambique | Tablet | 1.0K | NOS | $6.68 | $7K | CHENNAI SEA | Maputo | SEA |
| SUPPLIER #12 — V 2 IMPEX · 1 shipments · $13K | |||||||||||
| 37 | Oct 2025 | PRINCE FARMA SA | Angola | 69.0K | NOS | $0.190 | $13K | AHMEDABAD ICD | LUANDA | ICD | |
| SUPPLIER #13 — SANJEEVANI BIO-TECH EXIM PVT LTD · 2 shipments · $12K | |||||||||||
| 38 | Dec 2025 | UNLISTED BUYER | Somalia | Tablet | 5.9K | NOS | $1.59 | $9K | AHMEDABAD ICD | MOGADISHU | ICD |
| 39 | Dec 2025 | UNLISTED BUYER | Somalia | Tablet | 2.0K | NOS | $1.43 | $3K | AHMEDABAD ICD | BERBERA | ICD |
| SUPPLIER #14 — SAVORITE PHARMACEUTICALS PVT LTD · 1 shipments · $7K | |||||||||||
| 40 | Dec 2025 | UNLISTED BUYER | Cameroon | Cream | 42.9K | NOS | $0.167 | $7K | NHAVA SHEVA SEA (JNPT) | Douala | SEA |
| SUPPLIER #15 — AURA LIFECARE PVT LTD · 2 shipments · $6K | |||||||||||
| 41 | Oct 2025 | LUA COMERCIO GERAL LIMITADA | Angola | Cream | 2.0K | NOS | $1.64 | $3K | MUNDRA SEA | Luanda | SEA |
| 42 | Dec 2025 | GUMAR INTERNATIONAL (FZC) | Angola | Cream | 2.0K | NOS | $1.66 | $3K | MUNDRA SEA | Luanda | SEA |
| SUPPLIER #16 — HANSI TRADERS · 9 shipments · $3K | |||||||||||
| 43 | Nov 2025 | ELTON TATENDA GUWU | South Africa | Tablet | 900 | NOS | $0.346 | $311.78 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 44 | Nov 2025 | ELTON TATENDA GUWU | South Africa | Tablet | 900 | NOS | $0.346 | $311.78 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 45 | Nov 2025 | ELTON TATENDA GUWU | South Africa | Tablet | 600 | NOS | $0.673 | $403.82 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 46 | Nov 2025 | ELTON TATENDA GUWU | South Africa | Tablet | 900 | NOS | $0.349 | $314.46 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 47 | Nov 2025 | ELTON TATENDA GUWU | South Africa | Tablet | 600 | NOS | $0.679 | $407.30 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 48 | Nov 2025 | ELTON TATENDA GUWU | South Africa | Tablet | 900 | NOS | $0.349 | $314.46 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 49 | Nov 2025 | UNKNOWN BUYER | South Africa | Tablet | 900 | NOS | $0.349 | $314.46 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 50 | Nov 2025 | ELTON TATENDA GUWU | South Africa | Tablet | 900 | NOS | $0.349 | $314.46 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 51 | Nov 2025 | UNKNOWN BUYER | South Africa | Tablet | 900 | NOS | $0.349 | $314.46 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| SUPPLIER #17 — BEYOND LIFE LINE · 1 shipments · $3K | |||||||||||
| 52 | Nov 2025 | GROUPE SIMA-AICHA COMMERCIAL SARL | Guinea-Bissau | Suspension | 4.9K | NOS | $0.544 | $3K | SONEPAT ICD | BISSAU | ICD |
| SUPPLIER #18 — BIO PHARMA PRIMO IMPEX · 2 shipments · $2K | |||||||||||
| 53 | Nov 2025 | MINISTRY OF HEALTH & SOCIAL WELFARE | Liberia | Tablet | 17.8K | NOS | $0.065 | $1K | MUNDRA SEA | Monrovia | SEA |
| 54 | Nov 2025 | MINISTRY OF HEALTH & SOCIAL WELFARE | Liberia | Tablet | 12.2K | NOS | $0.065 | $795.98 | MUNDRA SEA | Monrovia | SEA |
| SUPPLIER #19 — PATSONS INTERNATIONAL · 1 shipments · $1K | |||||||||||
| 55 | Nov 2025 | LUSAKA PHARMACEUTICALS LTD | Zambia | Tablet | 5.0K | NOS | $0.278 | $1K | AHMEDABAD AIR | LUSAKA | AIR |
| SUPPLIER #20 — MEDNEXT BIOTECH LTD · 2 shipments · $1K | |||||||||||
| 56 | Dec 2025 | OFFICE PHARMACEUTIQUE NATIONALE | Gabon | Tablet | 100 | NOS | $3.88 | $388.06 | NHAVA SHEVA SEA (JNPT) | Libreville | SEA |
| 57 | Dec 2025 | OFFICE PHARMACEUTIQUE NATIONALE | Gabon | Tablet | 100 | NOS | $6.65 | $665.25 | NHAVA SHEVA SEA (JNPT) | Libreville | SEA |
| SUPPLIER #21 — SONIA LABORATORY PVT LTD · 2 shipments · $1K | |||||||||||
| 58 | Dec 2025 | SONIA FARMACIA SARL | Guinea-Bissau | Tablet | 510 | NOS | $0.347 | $176.94 | NHAVA SHEVA SEA (JNPT) | Bissau | SEA |
| 59 | Dec 2025 | SONIA PHARMACY | Equatorial Guinea | Cream | 3.0K | NOS | $0.282 | $846.80 | NHAVA SHEVA SEA (JNPT) | Bata | SEA |
| SUPPLIER #22 — EXGEN CARE PVT LTD · 1 shipments · $887.58 | |||||||||||
| 60 | Oct 2025 | UNLISTED BUYER | Angola | Cream | 5.0K | PCS | $0.178 | $887.58 | NHAVA SHEVA SEA (JNPT) | Luanda | SEA |
| SUPPLIER #23 — FLOURISH PHARMA · 1 shipments · $621.44 | |||||||||||
| 61 | Dec 2025 | PRINCE PHARMA | DR Congo | Tablet | 1.5M | NOS | $0.0004 | $621.44 | NHAVA SHEVA SEA (JNPT) | Matadi | SEA |
| SUPPLIER #24 — NUMED PHARMA DISTRIBUTOR · 4 shipments · $509.28 | |||||||||||
| 62 | Nov 2025 | LIFELINE PHARMACEUTICALS OF | Lesotho | Tablet | 510 | NOS | $0.499 | $254.57 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 63 | Nov 2025 | LIFELINE PHARMACEUTICALS OF | Lesotho | Tablet | 510 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 64 | Nov 2025 | LIFELINE PHARMACEUTICALS OF | Lesotho | Tablet | 510 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 65 | Nov 2025 | LIFELINE PHARMACEUTICALS OF | Lesotho | Tablet | 510 | NOS | $0.499 | $254.71 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| SUPPLIER #25 — INTERMED LABORATORIES PVT LTD · 2 shipments · $345.81 | |||||||||||
| 66 | Dec 2025 | SHANI LDA | Mozambique | Tablet | 4.8K | NOS | $0.072 | $345.81 | NHAVA SHEVA SEA (JNPT) | Maputo | SEA |
| 67 | Dec 2025 | SHANI LDA | Mozambique | Tablet | 4.8K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Maputo | SEA |
| SUPPLIER #26 — SAVA HEALTHCARE LTD · 3 shipments · $245.66 | |||||||||||
| 68 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 1 | NOS | $13.67 | $13.67 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 69 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 6 | NOS | $13.65 | $81.91 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 70 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 11 | NOS | $13.64 | $150.08 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| SUPPLIER #27 — MEDISKY HEALTHCARE · 1 shipments · $194.44 | |||||||||||
| 71 | Oct 2025 | OCEAN HEALTHCARE | Somalia | Tablet | 200 | NOS | $0.972 | $194.44 | CHENNAI AIR | MOGADISCHU | AIR |
| SUPPLIER #28 — BALAXI PHARMACEUTICALS LTD · 1 shipments · $36.22 | |||||||||||
| 72 | Dec 2025 | BALAXI HEALTHCARE ANGOLA LDA | Angola | Cream | 20.0K | NOS | $0.0018 | $36.22 | NHAVA SHEVA SEA (JNPT) | Luanda | SEA |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
9 countries · 24 shipments · $130K · 15 Indian suppliers · 14 buyers
SHIPMENTS
24
USD
$130K
COUNTRIES
9
SUPPLIERS
15
BUYERS
14
HHI
1,674
moderate
Top 9 destination countries in Asia
1
United Arab Emirates (54.8%)
$71K
2
Sri Lanka (24.3%)
$32K
3
Oman (7.6%)
$10K
4
Bhutan (6.7%)
$9K
5
Qatar (3.5%)
$4K
6
Bahrain (2.1%)
$3K
7
Iraq (0.5%)
$691.78
8
Turkey (0.5%)
$628.48
9
Singapore (0.1%)
$108.87
Top 15 Indian suppliers into Asia
1
FREDUN PHARMACEUTICALS LTD
$32K
2
INNOVA CAPTAB LTD
$31K
3
MICRO LABS LTD
$22K
4
SMP LIFECARE
$11K
5
MERRIL PHARMA PVT LTD
$10K
6
JMB PHARMACEUTICALS PVT LTD
$9K
7
AURA LIFECARE PVT LTD
$7K
8
ORBIT PHARMACEUTICALS
$4K
9
MILTON LIFECARE PVT LTD
$3K
10
GOLDFIELD HEALTHCARE
$689.16
11
M T MADON EXPORTS
$628.48
12
SANITAS MEDTECH INSTITUTE PVT LTD
$108.87
13
CLOVERLEAF ECOM PVT LTD
$14.34
14
MOVID IMPEX
$4.34
15
DISTINCT IMPEX PVT LTD
$2.62
Top 12 Asia importers
1
GEORGE STEUART HEALTH (PVT) LTD · Sri Lanka
$32K
2
NOOR AL DAR GENERAL TRADING LLC · United Arab Emirates
$31K
3
IMPERIAL MEDICAL SOLUTIONS FZE · United Arab Emirates
$22K
4
EPHESUS GENERAL TRADING FZE · United Arab Emirates
$11K
5
KMT PHAMCEUTICALS& MEDICAL SUPP · Bhutan
$9K
6
GUMAR INTERNATIONAL (FZC) · United Arab Emirates
$7K
7
NANO PHARMA INTERNATIONAL FOR · Oman
$5K
8
UNIPHARM TRADING · Qatar
$4K
9
GULF PHARMACIES W.L.L · Bahrain
$3K
10
BMS TIBBI MALZEMELER VE ILAC ITHALA · Turkey
$628.48
11
SUCCESS INTER LINK PTE LTD · Singapore
$108.87
12
EMIRATES POST GROUP · United Arab Emirates
$18.69
Top 3 dosage forms
1
Tablet
$98K
2
Suspension
$25K
3
Unknown
$7K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 9 | $94K | $10K |
| Nov | 9 | $18K | $2K |
| Dec | 6 | $19K | $3K |
Shipment register · 24 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — FREDUN PHARMACEUTICALS LTD · 2 shipments · $32K | |||||||||||
| 1 | Oct 2025 | GEORGE STEUART HEALTH (PVT) LTD | Sri Lanka | Tablet | 440.2K | NOS | $0.072 | $32K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 2 | Oct 2025 | GEORGE STEUART HEALTH (PVT) LTD | Sri Lanka | Tablet | 1 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| SUPPLIER #2 — INNOVA CAPTAB LTD · 4 shipments · $31K | |||||||||||
| 3 | Oct 2025 | NOOR AL DAR GENERAL TRADING LLC | United Arab Emirates | Tablet | 19.6K | NOS | $0.535 | $10K | CHAWAPAYAL ICD | Jebel Ali | ICD |
| 4 | Oct 2025 | NOOR AL DAR GENERAL TRADING LLC | United Arab Emirates | Tablet | 9.6K | NOS | $0.535 | $5K | CHAWAPAYAL ICD | Jebel Ali | ICD |
| 5 | Oct 2025 | NOOR AL DAR GENERAL TRADING LLC | United Arab Emirates | Tablet | 9.6K | NOS | $0.559 | $5K | CHAWAPAYAL ICD | JEBEL ALI | ICD |
| 6 | Oct 2025 | NOOR AL DAR GENERAL TRADING LLC | United Arab Emirates | Tablet | 19.6K | NOS | $0.535 | $10K | CHAWAPAYAL ICD | JEBEL ALI | ICD |
| SUPPLIER #3 — MICRO LABS LTD · 2 shipments · $22K | |||||||||||
| 7 | Oct 2025 | IMPERIAL MEDICAL SOLUTIONS FZE | United Arab Emirates | Tablet | 200 | PCS | $53.78 | $11K | HOSUR ICD TAMILNADU | AEJEA | ICD |
| 8 | Dec 2025 | IMPERIAL MEDICAL SOLUTIONS FZE | United Arab Emirates | Tablet | 100 | KGS | $110.70 | $11K | HOSUR ICD | JEBEL ALI | ICD |
| SUPPLIER #4 — SMP LIFECARE · 1 shipments · $11K | |||||||||||
| 9 | Oct 2025 | EPHESUS GENERAL TRADING FZE | United Arab Emirates | Suspension | 24.0K | NOS | $0.461 | $11K | AHMEDABAD ICD | Jebel Ali | ICD |
| SUPPLIER #5 — MERRIL PHARMA PVT LTD · 2 shipments · $10K | |||||||||||
| 10 | Nov 2025 | NANO PHARMA INTERNATIONAL FOR | Oman | Suspension | 10.0K | NOS | $0.499 | $5K | MUNDRA SEA | Salalah | SEA |
| 11 | Nov 2025 | UNKNOWN BUYER | Oman | Suspension | 10.0K | NOS | $0.499 | $5K | MUNDRA SEA | Salalah | SEA |
| SUPPLIER #6 — JMB PHARMACEUTICALS PVT LTD · 1 shipments · $9K | |||||||||||
| 12 | Oct 2025 | KMT PHAMCEUTICALS& MEDICAL SUPP | Bhutan | Tablet | 359 | NOS | $24.15 | $9K | JAIGAON LCS | Phuntsholing | ROAD |
| SUPPLIER #7 — AURA LIFECARE PVT LTD · 1 shipments · $7K | |||||||||||
| 13 | Nov 2025 | GUMAR INTERNATIONAL (FZC) | United Arab Emirates | 17.2K | NOS | $0.402 | $7K | MUNDRA SEA | Jebel Ali | SEA | |
| SUPPLIER #8 — ORBIT PHARMACEUTICALS · 1 shipments · $4K | |||||||||||
| 14 | Dec 2025 | UNIPHARM TRADING | Qatar | Suspension | 800 | NOS | $5.61 | $4K | AHMEDABAD AIR | DOHA | AIR |
| SUPPLIER #9 — MILTON LIFECARE PVT LTD · 1 shipments · $3K | |||||||||||
| 15 | Dec 2025 | GULF PHARMACIES W.L.L | Bahrain | Tablet | 150 | NOS | $18.23 | $3K | MUMBAI AIR (SAHAR) | BAHRAIN | AIR |
| SUPPLIER #10 — GOLDFIELD HEALTHCARE · 1 shipments · $689.16 | |||||||||||
| 16 | Nov 2025 | UNLISTED BUYER | Iraq | Tablet | 1.0K | PCS | $0.689 | $689.16 | MUMBAI AIR (SAHAR) | BAGDAD, METROPOLITAN | AIR |
| SUPPLIER #11 — M T MADON EXPORTS · 2 shipments · $628.48 | |||||||||||
| 17 | Nov 2025 | BMS TIBBI MALZEMELER VE ILAC ITHALA | Turkey | Tablet | 1.0K | NOS | $0.278 | $284.01 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 18 | Dec 2025 | BMS TIBBI MALZEMELER VE ILAC ITHALA | Turkey | Tablet | 1.1K | NOS | $0.302 | $344.47 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #12 — SANITAS MEDTECH INSTITUTE PVT LTD · 1 shipments · $108.87 | |||||||||||
| 19 | Nov 2025 | SUCCESS INTER LINK PTE LTD | Singapore | Tablet | 10 | NOS | $10.89 | $108.87 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #13 — CLOVERLEAF ECOM PVT LTD · 2 shipments · $14.34 | |||||||||||
| 20 | Nov 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 14 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 21 | Nov 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 14 | NOS | $1.02 | $14.34 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #14 — MOVID IMPEX · 1 shipments · $4.34 | |||||||||||
| 22 | Nov 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 9 | NOS | $0.483 | $4.34 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #15 — DISTINCT IMPEX PVT LTD · 2 shipments · $2.62 | |||||||||||
| 23 | Dec 2025 | UNLISTED BUYER | Iraq | Suspension | 50 | NOS | $0.026 | $1.31 | MUMBAI AIR (SAHAR) | Erbil Inter airport | SEA |
| 24 | Dec 2025 | UNLISTED BUYER | Iraq | Suspension | 50 | NOS | $0.026 | $1.31 | MUMBAI AIR (SAHAR) | Erbil Inter airport | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
3 countries · 5 shipments · $124K · 4 Indian suppliers · 4 buyers
SHIPMENTS
5
USD
$124K
COUNTRIES
3
SUPPLIERS
4
BUYERS
4
HHI
5,132
concentrated
Top 3 destination countries in Europe
1
Netherlands (80.0%)
$99K
2
France (20.0%)
$25K
3
Belgium · Belgium
$0.0000
Top 4 Indian suppliers into Europe
1
MICRO LABS LTD
$84K
2
RIPHARMA LABORATORIES LTD
$25K
3
MEDOPHARM
$15K
4
CIPLA LTD
$0.0000
Top 2 Europe importers
1
IMRES B.V · Netherlands
$57K
2
H.ESSERS & ZONEN INTERNATIONAL TRAN · Belgium
$0.0000
Top 1 dosage forms
1
Tablet
$124K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $40K | $20K |
| Nov | 2 | $84K | $42K |
| Dec | 1 | $0.0000 | $0.0000 |
Shipment register · 5 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MICRO LABS LTD · 2 shipments · $84K | |||||||||||
| 1 | Nov 2025 | IMRES B.V | Netherlands | Tablet | 385 | KGS | $108.70 | $42K | BANGALORE AIR | AMSTERDAM, SCHIPHOL | AIR |
| 2 | Nov 2025 | UNKNOWN BUYER | Netherlands | Tablet | 385 | KGS | $108.70 | $42K | BANGALORE AIR | AMSTERDAM, SCHIPHOL | AIR |
| SUPPLIER #2 — RIPHARMA LABORATORIES LTD · 1 shipments · $25K | |||||||||||
| 3 | Oct 2025 | UNLISTED BUYER | France | Tablet | 15.7K | NOS | $1.57 | $25K | NHAVA SHEVA SEA (JNPT) | Le Havre | SEA |
| SUPPLIER #3 — MEDOPHARM · 1 shipments · $15K | |||||||||||
| 4 | Oct 2025 | IMRES B.V | Netherlands | Tablet | 1.0K | THD | $15.28 | $15K | ENNORE SEA | Rotterdam | SEA |
| SUPPLIER #4 — CIPLA LTD · 1 shipments · $0.0000 | |||||||||||
| 5 | Dec 2025 | H.ESSERS & ZONEN INTERNATIONAL TRAN | Belgium | Tablet | 0 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | BRUSSELS | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
9 countries · 21 shipments · $365K · 9 Indian suppliers · 8 buyers
SHIPMENTS
21
USD
$365K
COUNTRIES
9
SUPPLIERS
9
BUYERS
8
HHI
6,008
concentrated
Top 9 destination countries in Americas
1
United States (94.7%)
$345K
2
Venezuela (3.4%)
$12K
3
Jamaica (1.1%)
$4K
4
Haiti (0.6%)
$2K
5
British Virgin Islands (0.2%)
$618.75
6
Grenada (0.0%)
$132.67
7
Saint Kitts and Nevis (0.0%)
$89.53
8
Dominica (0.0%)
$56.00
9
Saint Lucia (0.0%)
$0.755
Top 9 Indian suppliers into Americas
1
CIPLA LTD
$273K
2
AMNEAL PHARMACEUTICALS PVT LTD
$72K
3
ALDE MEDI IMPEX LTD
$12K
4
RYVIS PHARMA PVT LTD
$4K
5
SANAR HEALTHCARE GLOBAL PVT LTD
$2K
6
SARA TRADING CORP
$361.46
7
AANYA GLOBAL
$258.04
8
VEA IMPEX (I) PVT LTD
$145.53
9
DHRUVI ENTERPRISES
$132.67
Top 7 Americas importers
1
CIPLA USA INC · United States
$273K
2
AMNEAL PHARMACEUTICALS LLC · United States
$72K
3
BIOGLASS PHARMACEUTICAL CASA DEREPR · Venezuela
$12K
4
RPPL · Jamaica
$4K
5
ZANMI LASANTE · Haiti
$2K
6
VANTERPOOL ENTERPRISES LTD · British Virgin Islands
$360.71
7
DALKHAN MEDICAL SUPPLIES LTD · Saint Lucia
$0.755
Top 2 dosage forms
1
Suspension
$277K
2
Tablet
$87K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $12K | $12K |
| Nov | 5 | $331K | $66K |
| Dec | 15 | $21K | $1K |
Shipment register · 21 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — CIPLA LTD · 2 shipments · $273K | |||||||||||
| 1 | Nov 2025 | CIPLA USA INC | United States | Suspension | 15.5K | NOS | $8.74 | $136K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| 2 | Nov 2025 | CIPLA USA INC | United States | Suspension | 15.7K | NOS | $8.74 | $137K | MUMBAI AIR (SAHAR) | NEWARK, NJ | AIR |
| SUPPLIER #2 — AMNEAL PHARMACEUTICALS PVT LTD · 2 shipments · $72K | |||||||||||
| 3 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 2.4K | NOS | $22.85 | $54K | MUNDRA SEA | Savannah | SEA |
| 4 | Dec 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 1.2K | NOS | $15.24 | $18K | AHMEDABAD AIR | CHICAGO O'HARE INT'L | AIR |
| SUPPLIER #3 — ALDE MEDI IMPEX LTD · 1 shipments · $12K | |||||||||||
| 5 | Oct 2025 | BIOGLASS PHARMACEUTICAL CASA DEREPR | Venezuela | Tablet | 47.0K | NOS | $0.266 | $12K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| SUPPLIER #4 — RYVIS PHARMA PVT LTD · 6 shipments · $4K | |||||||||||
| 6 | Nov 2025 | RPPL | Jamaica | Suspension | 4.3K | NOS | $0.676 | $3K | NHAVA SHEVA SEA (JNPT) | Kingston | SEA |
| 7 | Nov 2025 | RPPL | Jamaica | Suspension | 1.8K | NOS | $0.602 | $1K | NHAVA SHEVA SEA (JNPT) | Kingston | SEA |
| 8 | Dec 2025 | RPPL | Jamaica | Tablet | 110 | NOS | $0.030 | $3.31 | MUMBAI AIR (SAHAR) | KINGSTON | SEA |
| 9 | Dec 2025 | RPPL | Jamaica | Tablet | 64 | NOS | $0.117 | $7.52 | NHAVA SHEVA SEA (JNPT) | Kingston | SEA |
| 10 | Dec 2025 | RPPL | Jamaica | Tablet | 436 | NOS | $0.039 | $17.05 | NHAVA SHEVA SEA (JNPT) | Kingston | SEA |
| 11 | Dec 2025 | RPPL | Jamaica | Tablet | 1.4K | NOS | $0.0047 | $6.72 | NHAVA SHEVA SEA (JNPT) | Kingston | SEA |
| SUPPLIER #5 — SANAR HEALTHCARE GLOBAL PVT LTD · 1 shipments · $2K | |||||||||||
| 12 | Dec 2025 | ZANMI LASANTE | Haiti | Tablet | 66.7K | NOS | $0.031 | $2K | AHMEDABAD ICD | Port-au-Prince | ICD |
| SUPPLIER #6 — SARA TRADING CORP · 3 shipments · $361.46 | |||||||||||
| 13 | Dec 2025 | DALKHAN MEDICAL SUPPLIES LTD | Saint Lucia | Tablet | 10 | NOS | $0.026 | $0.259 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| 14 | Dec 2025 | DALKHAN MEDICAL SUPPLIES LTD | Saint Lucia | Suspension | 13 | NOS | $0.038 | $0.496 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| 15 | Dec 2025 | VANTERPOOL ENTERPRISES LTD | British Virgin Islands | Tablet | 100 | NOS | $3.61 | $360.71 | MUMBAI AIR (SAHAR) | TORTOLA | AIR |
| SUPPLIER #7 — AANYA GLOBAL · 1 shipments · $258.04 | |||||||||||
| 16 | Dec 2025 | UNLISTED BUYER | British Virgin Islands | Suspension | 120 | NOS | $2.15 | $258.04 | MUMBAI AIR (SAHAR) | TORTOLA | AIR |
| SUPPLIER #8 — VEA IMPEX (I) PVT LTD · 3 shipments · $145.53 | |||||||||||
| 17 | Dec 2025 | UNLISTED BUYER | Dominica | Suspension | 20 | NOS | $2.80 | $56.00 | MUMBAI AIR (SAHAR) | DOMINICA | AIR |
| 18 | Dec 2025 | UNLISTED BUYER | Saint Kitts and Nevis | Tablet | 50 | NOS | $1.76 | $88.00 | MUMBAI AIR (SAHAR) | ST KITTS | AIR |
| 19 | Dec 2025 | UNLISTED BUYER | Saint Kitts and Nevis | Suspension | 50 | NOS | $0.031 | $1.53 | MUMBAI AIR (SAHAR) | ST KITTS | SEA |
| SUPPLIER #9 — DHRUVI ENTERPRISES · 2 shipments · $132.67 | |||||||||||
| 20 | Dec 2025 | UNLISTED BUYER | Grenada | Suspension | 32 | NOS | $2.65 | $84.91 | MUMBAI AIR (SAHAR) | GRENADA | AIR |
| 21 | Dec 2025 | UNLISTED BUYER | Grenada | Suspension | 18 | NOS | $2.65 | $47.76 | MUMBAI AIR (SAHAR) | GRENADA | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 3 shipments · $11K · 2 Indian suppliers · 2 buyers
SHIPMENTS
3
USD
$11K
COUNTRIES
1
SUPPLIERS
2
BUYERS
2
HHI
6,511
concentrated
Top 1 destination countries in Oceania
1
Papua New Guinea (100.0%)
$11K
Top 2 Indian suppliers into Oceania
1
FINDLIFE PHARMACEUTICAL
$9K
2
ARIHANT EXPORTERS
$3K
Top 1 Oceania importers
1
SESAGO HEALTH CARE LTD · Papua New Guinea
$3K
Top 1 dosage forms
1
Tablet
$11K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 3 | $11K | $4K |
Shipment register · 3 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — FINDLIFE PHARMACEUTICAL · 1 shipments · $9K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Papua New Guinea | Tablet | 9.6K | NOS | $0.917 | $9K | MUMBAI AIR (SAHAR) | PORT MORESBY | AIR |
| SUPPLIER #2 — ARIHANT EXPORTERS · 2 shipments · $3K | |||||||||||
| 2 | Dec 2025 | SESAGO HEALTH CARE LTD | Papua New Guinea | Tablet | 2.5K | PCS | $1.000 | $3K | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
| 3 | Dec 2025 | SESAGO HEALTH CARE LTD | Papua New Guinea | Tablet | 2.5K | PCS | $0.011 | $28.70 | NHAVA SHEVA SEA (JNPT) | Port Moresby | SEA |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 55 Indian griseofulvin exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped griseofulvin in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | CIPLA LTD | PAREL MUMBAI MAHARASHTRA | 3 | $273K | Suspension, Tablet | Americas, Europe |
| 2 | SIDHAANT LIFE SCIENCES PVT LTD | GURUGRAM | 3 | $221K | Tablet | Africa |
| 3 | AGOG PHARMA LTD | VASAI EAST | 6 | $190K | Tablet | Africa |
| 4 | LEBEN LABORATORIES PVT LTD | AKOLA. MAHARASHTRA | 7 | $117K | Tablet | Africa |
| 5 | VIDACARE MEDICA PVT LTD | VIDYAVIHAR EAST | 6 | $113K | Tablet | Africa |
| 6 | MICRO LABS LTD | HOSUR | 4 | $106K | Tablet | Asia, Europe |
| 7 | AFRICURE PHARMACEUTICALS (INDIA) PVT LTD | MUMBAI | 3 | $78K | Tablet | Africa |
| 8 | AMNEAL PHARMACEUTICALS PVT LTD | RAJODA | 2 | $72K | Tablet | Americas |
| 9 | LABORATE PHARMACEUTICALS INDIA LTD | PANIPAT | 1 | $54K | Tablet | Africa |
| 10 | CIRON DRUGS AND PHARMACEUTICALS PVT LTD | PALGHAR | 2 | $42K | Suspension | Africa |
| 11 | FREDUN PHARMACEUTICALS LTD | MUMBAI | 2 | $32K | Tablet | Asia |
| 12 | INNOVA CAPTAB LTD | BADDI | 4 | $31K | Tablet | Asia |
| 13 | RIPHARMA LABORATORIES LTD | MAHARASHTRA | 1 | $25K | Tablet | Europe |
| 14 | BIOMATRIX HEALTHCARE PVT LTD | AHMADABAD | 1 | $22K | Tablet | Africa |
| 15 | RONAK EXIM PVT LTD | VADODARA | 2 | $19K | Suspension | Africa |
| 16 | BAL PHARMA LTD | BANGALORE | 3 | $18K | Tablet | Africa |
| 17 | MEDOPHARM | CHENNAI | 1 | $15K | Tablet | Europe |
| 18 | AURA LIFECARE PVT LTD | KARACHIYA TAL SAVLI | 3 | $13K | Cream | Africa, Asia |
| 19 | KAUSIKH THERAPEUTICS PVT LTD | CHENNAI | 2 | $13K | Tablet | Africa |
| 20 | V 2 IMPEX | AHMEDABAD | 1 | $13K | Africa | |
| 21 | ALDE MEDI IMPEX LTD | New Delhi | 1 | $12K | Tablet | Americas |
| 22 | SANJEEVANI BIO-TECH EXIM PVT LTD | AHMEDABAD | 2 | $12K | Tablet | Africa |
| 23 | SMP LIFECARE | VADODARA | 1 | $11K | Suspension | Asia |
| 24 | MERRIL PHARMA PVT LTD | AHMEDABAD | 2 | $10K | Suspension | Asia |
| 25 | FINDLIFE PHARMACEUTICAL | SURAT | 1 | $9K | Tablet | Oceania |
| 26 | JMB PHARMACEUTICALS PVT LTD | MUMBAI | 1 | $9K | Tablet | Asia |
| 27 | SAVORITE PHARMACEUTICALS PVT LTD | VADODARA | 1 | $7K | Cream | Africa |
| 28 | ORBIT PHARMACEUTICALS | AHMEDABAD | 1 | $4K | Suspension | Asia |
| 29 | RYVIS PHARMA PVT LTD | Mumbai | 6 | $4K | Suspension, Tablet | Americas |
| 30 | HANSI TRADERS | ANKLESHWAR | 9 | $3K | Tablet | Africa |
| 31 | MILTON LIFECARE PVT LTD | MUMBAI | 1 | $3K | Tablet | Asia |
| 32 | BEYOND LIFE LINE | DEHRADUN | 1 | $3K | Suspension | Africa |
| 33 | ARIHANT EXPORTERS | SURENDRANAGAR | 2 | $3K | Tablet | Oceania |
| 34 | SANAR HEALTHCARE GLOBAL PVT LTD | Ahmedabad | 1 | $2K | Tablet | Americas |
| 35 | BIO PHARMA PRIMO IMPEX | JAIPUR RAJASTHAN | 2 | $2K | Tablet | Africa |
| 36 | PATSONS INTERNATIONAL | ANAND | 1 | $1K | Tablet | Africa |
| 37 | MEDNEXT BIOTECH LTD | UDAIPUR | 2 | $1K | Tablet | Africa |
| 38 | SONIA LABORATORY PVT LTD | VADODARA | 2 | $1K | Tablet, Cream | Africa |
| 39 | EXGEN CARE PVT LTD | NOIDA | 1 | $887.58 | Cream | Africa |
| 40 | GOLDFIELD HEALTHCARE | Mumbai | 1 | $689.16 | Tablet | Asia |
| 41 | M T MADON EXPORTS | MUMBAI | 2 | $628.48 | Tablet | Asia |
| 42 | FLOURISH PHARMA | DAMAN | 1 | $621.44 | Tablet | Africa |
| 43 | NUMED PHARMA DISTRIBUTOR | MANGAON | 4 | $509.28 | Tablet | Africa |
| 44 | SARA TRADING CORP | JABALPUR | 3 | $361.46 | Tablet, Suspension | Americas |
| 45 | INTERMED LABORATORIES PVT LTD | CHENNAI | 2 | $345.81 | Tablet | Africa |
| 46 | AANYA GLOBAL | Mumbai | 1 | $258.04 | Suspension | Americas |
| 47 | SAVA HEALTHCARE LTD | PUNE | 3 | $245.66 | Tablet | Africa |
| 48 | MEDISKY HEALTHCARE | CHENNAI | 1 | $194.44 | Tablet | Africa |
| 49 | VEA IMPEX (I) PVT LTD | MUMBAI | 3 | $145.53 | Suspension, Tablet | Americas |
| 50 | DHRUVI ENTERPRISES | DAHISAR EAST | 2 | $132.67 | Suspension | Americas |
| 51 | SANITAS MEDTECH INSTITUTE PVT LTD | Narhen | 1 | $108.87 | Tablet | Asia |
| 52 | BALAXI PHARMACEUTICALS LTD | JUBILEE HILLS HYDERABAD | 1 | $36.22 | Cream | Africa |
| 53 | CLOVERLEAF ECOM PVT LTD | NAGPUR | 2 | $14.34 | Tablet | Asia |
| 54 | MOVID IMPEX | MUMBAI | 1 | $4.34 | Tablet | Asia |
| 55 | DISTINCT IMPEX PVT LTD | MUMBAI | 2 | $2.62 | Suspension | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 54 global griseofulvin importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian griseofulvin in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | CIPLA USA INC | United States | 2 | $273K | CIPLA LTD | Suspension |
| 2 | P.N.A | Senegal | 2 | $180K | SIDHAANT LIFE SCIENC… | Tablet |
| 3 | STE PRINCE PHARMA SARL | DR Congo | 6 | $113K | VIDACARE MEDICA PVT … | Tablet |
| 4 | ZEE PHARMACEUTICALS LTD | Uganda | 2 | $74K | LEBEN LABORATORIES P… | Tablet |
| 5 | AMNEAL PHARMACEUTICALS LLC | United States | 2 | $72K | AMNEAL PHARMACEUTICA… | Tablet |
| 6 | IMRES B.V | Netherlands | 2 | $57K | MICRO LABS LTD | Tablet |
| 7 | RGCO (PTY) LTD | South Africa | 1 | $54K | AGOG PHARMA LTD | Tablet |
| 8 | PLANET PHARMACEUTICALS LTD | Tanzania | 3 | $50K | AGOG PHARMA LTD | Tablet |
| 9 | AFRICURE PHARMACEUTICALS BURKINA S | Burkina Faso | 1 | $45K | AFRICURE PHARMACEUTI… | |
| 10 | LUSAKA MEDI CAMP LTD | Zambia | 1 | $34K | LEBEN LABORATORIES P… | Tablet |
| 11 | GITTOES PHARMACEUTICALS LTD | Kenya | 1 | $33K | AGOG PHARMA LTD | Tablet |
| 12 | GEORGE STEUART HEALTH (PVT) LTD | Sri Lanka | 2 | $32K | FREDUN PHARMACEUTICA… | Tablet |
| 13 | NOOR AL DAR GENERAL TRADING LLC | United Arab Emirates | 4 | $31K | INNOVA CAPTAB LTD | Tablet |
| 14 | ROYAL PHARMA 2011 UGANDA LTD | Uganda | 1 | $22K | AFRICURE PHARMACEUTI… | Tablet |
| 15 | IMPERIAL MEDICAL SOLUTIONS FZE | United Arab Emirates | 2 | $22K | MICRO LABS LTD | Tablet |
| 16 | ACE HEALTH CARE LDA | Mozambique | 1 | $22K | BIOMATRIX HEALTHCARE… | Tablet |
| 17 | ROXIN GHANA LTD | Ghana | 2 | $19K | RONAK EXIM PVT LTD | Suspension |
| 18 | PLANET PHARMACEUTICALS & CHEMICALS | Zimbabwe | 2 | $14K | BAL PHARMA LTD | Tablet |
| 19 | MAPUTO HEALTH CARE LDA | Mozambique | 2 | $13K | KAUSIKH THERAPEUTICS… | Tablet |
| 20 | PRINCE FARMA SA | Angola | 1 | $13K | V 2 IMPEX | |
| 21 | BIOGLASS PHARMACEUTICAL CASA DEREPR | Venezuela | 1 | $12K | ALDE MEDI IMPEX LTD | Tablet |
| 22 | EPHESUS GENERAL TRADING FZE | United Arab Emirates | 1 | $11K | SMP LIFECARE | Suspension |
| 23 | AUGUSTA LTD | Zambia | 1 | $11K | AFRICURE PHARMACEUTI… | Tablet |
| 24 | GUMAR INTERNATIONAL (FZC) | United Arab Emirates | 2 | $10K | AURA LIFECARE PVT LTD | Cream |
| 25 | MEDLINK PHARMACEUTICALS LTD | DR Congo | 1 | $9K | LEBEN LABORATORIES P… | Tablet |
| 26 | KMT PHAMCEUTICALS& MEDICAL SUPP | Bhutan | 1 | $9K | JMB PHARMACEUTICALS … | Tablet |
| 27 | NANO PHARMA INTERNATIONAL FOR | Oman | 1 | $5K | MERRIL PHARMA PVT LTD | Suspension |
| 28 | UNIPHARM TRADING | Qatar | 1 | $4K | ORBIT PHARMACEUTICALS | Suspension |
| 29 | RPPL | Jamaica | 6 | $4K | RYVIS PHARMA PVT LTD | Suspension, Tablet |
| 30 | LUA COMERCIO GERAL LIMITADA | Angola | 1 | $3K | AURA LIFECARE PVT LTD | Cream |
| 31 | GULF PHARMACIES W.L.L | Bahrain | 1 | $3K | MILTON LIFECARE PVT … | Tablet |
| 32 | GROUPE SIMA-AICHA COMMERCIAL SARL | Guinea-Bissau | 1 | $3K | BEYOND LIFE LINE | Suspension |
| 33 | SESAGO HEALTH CARE LTD | Papua New Guinea | 2 | $3K | ARIHANT EXPORTERS | Tablet |
| 34 | ELTON TATENDA GUWU | South Africa | 7 | $2K | HANSI TRADERS | Tablet |
| 35 | ZANMI LASANTE | Haiti | 1 | $2K | SANAR HEALTHCARE GLO… | Tablet |
| 36 | MINISTRY OF HEALTH & SOCIAL WELFARE | Liberia | 2 | $2K | BIO PHARMA PRIMO IMPEX | Tablet |
| 37 | LUSAKA PHARMACEUTICALS LTD | Zambia | 1 | $1K | PATSONS INTERNATIONAL | Tablet |
| 38 | OFFICE PHARMACEUTIQUE NATIONALE | Gabon | 2 | $1K | MEDNEXT BIOTECH LTD | Tablet |
| 39 | SONIA PHARMACY | Equatorial Guinea | 1 | $846.80 | SONIA LABORATORY PVT… | Cream |
| 40 | BMS TIBBI MALZEMELER VE ILAC ITHALA | Turkey | 2 | $628.48 | M T MADON EXPORTS | Tablet |
| 41 | PRINCE PHARMA | DR Congo | 1 | $621.44 | FLOURISH PHARMA | Tablet |
| 42 | LIFELINE PHARMACEUTICALS OF | Lesotho | 4 | $509.28 | NUMED PHARMA DISTRIB… | Tablet |
| 43 | VANTERPOOL ENTERPRISES LTD | British Virgin Islands | 1 | $360.71 | SARA TRADING CORP | Tablet |
| 44 | SHANI LDA | Mozambique | 2 | $345.81 | INTERMED LABORATORIE… | Tablet |
| 45 | REGENCY EXIM TRADE LTD | Mauritius | 3 | $245.66 | SAVA HEALTHCARE LTD | Tablet |
| 46 | OCEAN HEALTHCARE | Somalia | 1 | $194.44 | MEDISKY HEALTHCARE | Tablet |
| 47 | SONIA FARMACIA SARL | Guinea-Bissau | 1 | $176.94 | SONIA LABORATORY PVT… | Tablet |
| 48 | PHARMAVET LTD | Malawi | 2 | $172.92 | LEBEN LABORATORIES P… | Tablet |
| 49 | KARE PHARMACEUTICALS PLC | Ethiopia | 1 | $121.76 | LEBEN LABORATORIES P… | Tablet |
| 50 | SUCCESS INTER LINK PTE LTD | Singapore | 1 | $108.87 | SANITAS MEDTECH INST… | Tablet |
| 51 | BALAXI HEALTHCARE ANGOLA LDA | Angola | 1 | $36.22 | BALAXI PHARMACEUTICA… | Cream |
| 52 | EMIRATES POST GROUP | United Arab Emirates | 3 | $18.69 | CLOVERLEAF ECOM PVT … | Tablet |
| 53 | DALKHAN MEDICAL SUPPLIES LTD | Saint Lucia | 2 | $0.755 | SARA TRADING CORP | Tablet, Suspension |
| 54 | H.ESSERS & ZONEN INTERNATIONAL TRAN | Belgium | 1 | $0.0000 | CIPLA LTD | Tablet |
This report covers 125 2025-Q4 Griseofulvin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/griseofulvin
Talk to our trade analyst
Need a custom griseofulvin report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/griseofulvin
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Griseofulvin product page
Live data, supplier directory, price trends, and trade route analysis